PCM
AGN

Pentwater Capital Management’s Allergan plc AGN Stock Holding History

Pentwater Capital Management’s Portfolio AGN Stock Details AGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q3 		– Sell
-40,000
Closed -$6.67M – 164
2018
Q2 		$6.67M Sell
40,000
-30,000
-43% -$4.82M 0.05% 66
2018
Q1 		$11.8M Sell
70,000
-290,000
-81% -$48.6M 0.08% 65
2017
Q4 		$58.9M Buy
360,000
+10,000
+3% +$1.79M 0.39% 34
2017
Q3 		$71.7M Buy
350,000
+50,000
+17% +$11.6M 0.62% 26
2017
Q2 		$72.9M Sell
300,000
-160,000
-35% -$37.6M 0.67% 31
2017
Q1 		$110M Sell
460,000
-455,000
-50% -$106M 1.34% 19
2016
Q4 		$192M Buy
915,000
+15,000
+2% +$3.11M 2.46% 9
2016
Q3 		$207M Sell
900,000
-280,000
-24% -$68.4M 1.92% 10
2016
Q2 		$273M Sell
1,180,000
-8,300
-0.7% -$1.91M 3.64% 7
2016
Q1 		$319M Sell
1,188,300
-303,600
-20% -$86.9M 2.34% 11
2015
Q4 		$466M Buy
+1,491,900
New +$444M 3.2% 8
2015
Q2 		– Sell
-1,235,000
Closed -$368M – 188
2015
Q1 		$368M Buy
1,235,000
+458,200
+59% +$131M 2.75% 11
2014
Q4 		$200M Buy
776,800
+560,000
+258% +$140M 1.42% 18
2014
Q3 		$52.3M Buy
+216,800
New +$48.5M 0.5% 40

Other funds holding AGN

AJ
Ashburton (Jersey) St Helier, Jersey $227M AUM
C
Cerebellum San Francisco, California $21.5M AUM
B
Barings Charlotte, North Carolina $5.64B AUM 18.33% 1-Year Est. Return
JJ
JDC-JSC New York $20.8M AUM 30.94% 1-Year Est. Return
VFA
Valeo Financial Advisors Carmel, Indiana $4.74B AUM 27.69% 1-Year Est. Return
OPS
Orion Portfolio Solutions Omaha, Nebraska $10.2B AUM 6.73% 1-Year Est. Return

Pentwater Capital Management's AGN Position: Q2 2020 in Review

Pentwater Capital Management sold out of Allergan plc (AGN) in Q2 2020, closing a stake of 1,694,042 shares — an estimated $300M sold.

Pentwater Capital Management first reported a position in AGN in Q3 2014 and held it in 22 quarters. The position peaked at $1.35B in Q4 2015. 7 funds tracked by Wall St. Rank hold AGN as of Q2 2020.

  • Pentwater Capital Management reported no remaining Allergan plc position as of Q2 2020 after selling out during the quarter.
  • Pentwater Capital Management sold 1,694,042 Allergan plc shares in Q2 2020, an estimated $300M.
  • Pentwater Capital Management first reported a position in Allergan plc in Q3 2014 and held it in 22 quarters.
  • Pentwater Capital Management's Allergan plc position peaked at $1.35B in Q4 2015.
  • 7 funds tracked by Wall St. Rank held Allergan plc as of Q2 2020.

Based on Pentwater Capital Management's 13F filing for Q2 2020, filed 14 Aug 2020.